SCHEMBL9560090

SCHEMBL9560090

CC(C)(C)OC(=O)C=Cc1cc(C(F)(F)F)ccc1CCCCCCCCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RXRA P19793 5/20 0.49
NR1H2 P55055 5/20 0.49
NR1H3 Q13133 3/20 0.49
CYSLTR2 Q9NS75 1/20 0.47
CYSLTR1 Q9Y271 1/20 0.47
FAAH O00519 4/20 0.41
CES1 P23141 4/20 0.41
AKR1B10 O60218 2/20 0.39
AKR1B1 P15121 2/20 0.39
ALOX5 P09917 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
PLK1 P53350 1/20 0.37
ALDH1A1 P00352 1/20 0.37
ASAH1 Q13510 2/20 0.37
MAPT P10636 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9560089 1.00 RXRA (0.49) RXRANR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL9507469 0.89 CYSLTR2 (0.48) RXRANR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL9507472 0.89 CYSLTR2 (0.48) RXRANR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL10424229 0.86 CYSLTR2 (0.53) CYSLTR2CYSLTR1FAAHCES1HDAC1
SCHEMBL10424230 0.86 CYSLTR2 (0.53) CYSLTR2CYSLTR1FAAHCES1HDAC1
SCHEMBL10424350 0.78 CYSLTR2 (0.52) RXRANR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL9481085 0.77 CYSLTR2 (0.52) CYSLTR2CYSLTR1FAAHCES1HDAC1
SCHEMBL9721098 0.76 CYSLTR2 (0.44) CYSLTR2CYSLTR1HDAC1HDAC8ALDH1A1
SCHEMBL9721103 0.76 CYSLTR2 (0.44) CYSLTR2CYSLTR1HDAC1HDAC8ALDH1A1
SCHEMBL9560179 0.74 CYSLTR2 (0.56) RXRANR1H2NR1H3CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0358240-B1 INTERMEDIATES FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1993-06-09 EP disclosed
US-5189226-A Chemical intermediate for diacid SMITHKLINE BEECHAM CORPORATION (US) 1993-02-23 US disclosed
US-5034537-A Alpha-methyl-4-halobenzenemethanamine salts of acids for cardiovascular disorders, respiratory system disorders and antiallergens SMITHKLINE BEECHAM CORPORATION (US) 1991-07-23 US disclosed
US-4937253-A LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1990-06-26 US disclosed
EP-0202759-B1 LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1990-06-20 EP disclosed
EP-0365149-A2 Leukotriene antagonist prodrugs SMITHKLINE BEECHAM CORPORATION (US) 1990-04-25 EP disclosed
EP-0358240-A2 Intermediates for the preparation of leukotriene antagonists SMITHKLINE BEECHAM CORPORATION (US) 1990-03-14 EP disclosed
US-4874792-A RESPIRATORY SYSTEM DISORDERS SMITHKLINE BECKMAN CORPORATION (US) 1989-10-17 US disclosed
US-4820719-A ANTIALLERGENS, ANTIINFLAMMATORY, ANTIISCHEMIC AND HYPOTENSIVE AGENTS SMITHKLINE BECKMAN CORPORATION (US) 1989-04-11 US disclosed
EP-0202759-A2 Leukotriene antagonists SMITHKLINE BEECHAM CORPORATION (US) 1986-11-26 EP disclosed